PRZOOM - /newswire/ -
Holmes Chapel, Cheshire, United Kingdom, 2009/08/18 - Exco InTouch, the leading provider of patient communication solutions for the pharmaceutical and healthcare sectors, announces that its secure mobile data capture platform.
REACT CELL, significantly improves patient retention and compliance in clinical studies. During a recent clinical trial utilizing Exco InTouch technology for eDiary completion, REACT CELL was proven to improve patient diary compliance by 95% when compared with the number of expected responses.
REACT CELL from Exco InTouch is a mobile Internet-enabled data capture technology that can be customized to create electronic patient reported outcomes (ePRO) tools such as eDiaries. Patients receive a text message which contains a link to a secure mobile Internet service containing the eDiary. The patient connects to the service via mobile Internet and enters a unique PIN number to access the eDiary questionnaire. Exco InTouch's technology enables a wide range of questions to be presented and viewed on any mobile phone. In addition, questionnaires can be customized to improve user interface by including widgets such as radio buttons and check boxes.
During a recent clinical study, Exco InTouch was asked to create a secure mobile Internet eDiary to collect smoking cessation data directly from the patient. The trial included 200 randomized patients who were required to answer seven questions daily before 9am during a six-month period. The sponsor also required online data access and real-time alerting for key data items, as well as email alerts to sites for potential interventions. Exco InTouch developed an easy-to-use eDiary, integrated with Exco InTouch's patient communication technology, enabling the sponsor to send timed reminders to patients via text message.
In response to the sponsor's reporting requirements Exco InTouch also built real-time reporting into the system, which enables the sponsor to view patients' eDiary responses as they are submitted and respond quickly to any issues. Through using REACT CELL technology, all 200 patients completed the eDiary using mobile phones. In addition, the number of actual completed questions was 95% more than the number of expected responses, reflecting the increased patient compliance resulting from the use of Exco InTouch's technology.
"Traditional methods of patient reporting such as paper diaries and telephone conversations can have low levels of compliance, in addition to being time-consuming for the sponsor," comments Tim Davis, CEO of Exco In Touch. "It is encouraging to see such great results from the use of REACT CELL in this particular study. Exco InTouch places an emphasis on developing patient communication solutions that are easy to use for patients and clinic staff, and which significantly improve patient compliance."
For further information on the Exco InTouch range of solutions, please call +44 1279 408 210 or +1 949 725 2946
About Exco InTouch
Exco InTouch (excointouch.com) is the leading provider of interactive patient communication solutions using internet and cell phone technology. Using a combination of software and services, Exco InTouch offers BioPharma sponsors, CROs and patient recruitment agencies the opportunity to improve patient recruitment, retention and compliance using timely notifications, alerts and two-way messages.
Additionally, Exco collects electronic patient reported outcomes (ePRO) and diary data using standard cell phone technology which is both cost effective for sponsors and extremely easy and convenient for trial subjects. These solutions are currently being used by hundreds of thousands of patients in over 70 countries, delivered in the local language and are fully compliant with HIPAA regulations, FDA CFR 21 Part 11 and all electronic communication privacy directives.